TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
TFA Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was 85.2%. For fiscal 2025 it was -12.4%, against -18.1% the year before. The highest annual figure on record is 85.2% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -12.4% | +5.6 |
| FY2024 | Dec 31, 2024 | -18.1% | −103.2 |
| FY2023 | Dec 31, 2023 | 85.2% | +1436.1 |
| FY2022 | Dec 31, 2022 | -1350.9% | −1295.1 |
| FY2021 | Dec 31, 2021 | -55.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | 285.6% | – |
See a number that looks wrong?